{"transactions":[{"id":691888,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:38:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":961},"source":{"system":"sec-edgar","filing":"0001193125-26-343079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343079/ownership.xml","form_type":"4"}},{"id":691887,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-11T01:38:03.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":961,"source":{"system":"sec-edgar","filing":"0001193125-26-343079","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343079/ownership.xml","form_type":"4"}},{"id":1071380,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:32:57.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":17300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":17300,"derivative":{"underlying":"Common Stock","underlying_shares":17300},"source":{"system":"sec-edgar","filing":"0000950170-25-105930","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105930/ownership.xml","form_type":"4"}},{"id":1084027,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:35:23.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":5,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":12,"derivative":{"underlying":"Common Stock","underlying_shares":17},"source":{"system":"sec-edgar","filing":"0000950170-25-097267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097267/ownership.xml","form_type":"4"}},{"id":1084026,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock (post-reverse split May ACTIVE)","published_at":"2025-07-21T20:35:23.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":6,"source":{"system":"sec-edgar","filing":"0000950170-25-097267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097267/ownership.xml","form_type":"4"}},{"id":1228502,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228501,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":false,"shares":3,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 16,500 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 16,500 (11 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":4,"derivative":{"underlying":"Common Stock","underlying_shares":3},"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228500,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":36,"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1228499,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2025-03-04T21:35:19.000Z","date":"2025-03-02","kind":"exercise","planned":false,"acquired":true,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":34,"source":{"system":"sec-edgar","filing":"0000950170-25-032197","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025032197/ownership.xml","form_type":"4"}},{"id":1436928,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":272,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":272},"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436927,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023."}],"balance_after":41,"derivative":{"underlying":"Common Stock","underlying_shares":42},"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436926,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":272,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1166,"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1436925,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-08-09T20:33:05.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":894,"source":{"system":"sec-edgar","filing":"0000950170-24-094816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024094816/ownership.xml","form_type":"4"}},{"id":1451201,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:35:11.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":12825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on July 17, 2025."}],"balance_after":12825,"derivative":{"underlying":"Common Stock","underlying_shares":12825},"source":{"system":"sec-edgar","filing":"0000950170-24-084952","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084952/ownership.xml","form_type":"4"}},{"id":1596315,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-03-05T21:12:11.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":false,"shares":3667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":3667,"derivative":{"underlying":"Common Stock","underlying_shares":3667},"source":{"system":"sec-edgar","filing":"0000950170-24-025915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025915/ownership.xml","form_type":"4"}},{"id":1596314,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-03-05T21:12:11.000Z","date":"2024-03-02","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the reporting person was granted 16,500 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-025915","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025915/ownership.xml","form_type":"4"}},{"id":1596313,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-03-05T21:12:11.000Z","date":"2024-03-03","kind":"exercise","planned":false,"acquired":true,"shares":3667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":37504,"source":{"system":"sec-edgar","filing":"0000950170-24-025915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025915/ownership.xml","form_type":"4"}},{"id":1596312,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-03-05T21:12:11.000Z","date":"2024-03-02","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":33837,"source":{"system":"sec-edgar","filing":"0000950170-24-025915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024025915/ownership.xml","form_type":"4"}},{"id":1666505,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2024-01-30T23:04:47.000Z","date":"2024-01-28","kind":"exercise","planned":false,"acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0000950170-24-009003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024009003/ownership.xml","form_type":"4"}},{"id":1666504,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2024-01-30T23:04:47.000Z","date":"2024-01-28","kind":"exercise","planned":false,"acquired":true,"shares":1833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":28337,"source":{"system":"sec-edgar","filing":"0000950170-24-009003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024009003/ownership.xml","form_type":"4"}},{"id":1810865,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T12:41:08.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":false,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023."}],"balance_after":3667,"derivative":{"underlying":"Common Stock","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001209191-23-045263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045263/doc4.xml","form_type":"4"}},{"id":1810864,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T12:41:08.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":false,"shares":11979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023."}],"balance_after":11979,"derivative":{"underlying":"Common Stock","underlying_shares":11979},"source":{"system":"sec-edgar","filing":"0001209191-23-045263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045263/doc4.xml","form_type":"4"}},{"id":1810863,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2023-08-10T12:41:08.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":true,"shares":1833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":26504,"source":{"system":"sec-edgar","filing":"0001209191-23-045263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045263/doc4.xml","form_type":"4"}},{"id":1810862,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2023-08-10T12:41:08.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":true,"shares":11979,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":24671,"source":{"system":"sec-edgar","filing":"0001209191-23-045263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045263/doc4.xml","form_type":"4"}},{"id":1965883,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-07T21:44:16.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":16500,"derivative":{"exercise_price":2.15,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-23-016789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016789/doc4.xml","form_type":"4"}},{"id":1965882,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:44:16.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on March 2, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on March 2, 2024."}],"balance_after":16500,"derivative":{"underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-23-016789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016789/doc4.xml","form_type":"4"}},{"id":1965881,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Restricted Stock Unit","published_at":"2023-03-07T21:44:16.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":3666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 7, 2022, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":7334,"derivative":{"underlying":"Common Stock","underlying_shares":3666},"source":{"system":"sec-edgar","filing":"0001209191-23-016789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016789/doc4.xml","form_type":"4"}},{"id":1965880,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO"}}],"security":"Common Stock","published_at":"2023-03-07T21:44:16.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":3666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":12692,"source":{"system":"sec-edgar","filing":"0001209191-23-016789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123016789/doc4.xml","form_type":"4"}},{"id":2042180,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-01-30T18:04:55.000Z","date":"2023-01-29","kind":"exercise","acquired":false,"shares":1834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":1833,"derivative":{"underlying":"Common Stock","underlying_shares":1834},"source":{"system":"sec-edgar","filing":"0001209191-23-005420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123005420/doc4.xml","form_type":"4"}},{"id":2042179,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2023-01-30T18:04:55.000Z","date":"2023-01-29","kind":"exercise","acquired":true,"shares":1834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":9026,"source":{"system":"sec-edgar","filing":"0001209191-23-005420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123005420/doc4.xml","form_type":"4"}},{"id":2189423,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:08:34.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":23958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in two approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in two approximately equal annual installments beginning on August 8, 2023."}],"balance_after":23958,"derivative":{"underlying":"Common Stock","underlying_shares":23958},"source":{"system":"sec-edgar","filing":"0001209191-22-045183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122045183/doc4.xml","form_type":"4"}},{"id":2189422,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-10T20:08:34.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in three approximately equal annual installments beginning on August 8, 2023."}],"balance_after":5500,"derivative":{"exercise_price":4.32,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-22-045183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122045183/doc4.xml","form_type":"4"}},{"id":2189421,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:08:34.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on August 8, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in three approximately equal annual installments beginning on August 8, 2023."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-22-045183","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122045183/doc4.xml","form_type":"4"}},{"id":2240180,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-06-07T21:25:50.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"As previously disclosed in a Form 4 filed on March 4, 2022, the reporting person was granted 11,000 options on such date.  At the time of the grant, there were insufficient shares available for issuance under the Aptevo Therapeutics Inc. 2018 Stock Incentive Plan to make the full grant of equity award to the reporting person that was approved for issuance by Aptevo Therapeutics Inc.'s Compensation Committee.  As such, the equity award was split into two separate grants with the first portion of 11,000 options granted on March 4, 2022 and the second portion of 11,000 restricted stock units granted on June 7, 2022, following stockholder approval of an increase in shares available for issuance under the Aptevo Therapeutics Inc. 2018 Stock Incentive Plan (as Amended and Restated)."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on March 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":11000,"derivative":{"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-22-034879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122034879/doc4.xml","form_type":"4"}},{"id":2350365,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T23:11:17.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on March 3, 2023."}],"balance_after":11000,"derivative":{"exercise_price":5.3,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-22-016453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122016453/doc4.xml","form_type":"4"}},{"id":2419282,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-02-01T23:00:38.000Z","date":"2022-01-29","kind":"exercise","acquired":true,"shares":1833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 29, 2021, the reporting person was granted 5,500 RSUs, vesting in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":3667,"derivative":{"underlying":"Common Stock","underlying_shares":1833},"source":{"system":"sec-edgar","filing":"0001019056-22-000112","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905622000112/lamothe.xml","form_type":"4"}},{"id":2419281,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2022-02-01T23:00:38.000Z","date":"2022-01-29","kind":"exercise","acquired":true,"shares":1833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":7192,"source":{"system":"sec-edgar","filing":"0001019056-22-000112","document":"lamothe.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905622000112/lamothe.xml","form_type":"4"}},{"id":2854814,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2021-02-18T02:02:26.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on January 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU vests in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001019056-21-000145","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000145/lamothe.xml","form_type":"4"}},{"id":2854813,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T02:02:26.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on January 29, 2022."}],"balance_after":16500,"derivative":{"exercise_price":33.5,"expiration_date":"2031-01-29","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001019056-21-000145","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000145/lamothe.xml","form_type":"4"}},{"id":3074078,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":2140,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":2140,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":2140},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074077,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":7380,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These options vest in full on the one year anniversary of the date of grant."}],"balance_after":7380,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":7380},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074076,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":4814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This stock option award provides for vesting in three approximately equal annual installments beginning on February 28, 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":21.28,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":4814},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074075,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":4814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This stock option award provides for vesting in three approximately equal annual installments beginning on March 9, 2019. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":43.82,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":4814},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074074,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option award vested over three years, and the final one-third vested on June 1, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":30.1,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074073,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award vested over three years, and the final one-third vested on February 24, 2020."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":27.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":2407},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074072,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":3128,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award vested over three years, and the final one-third vested on March 1, 2019."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":41.58,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":3128},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074071,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1928,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award vested in full on March 10, 2018. This award was originally part of a grant from Emergent dated March 11, 2015, of which two-thirds were vested at the time of conversion to the issuer's equity pool."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":35.7,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":1928},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3074070,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-31T20:51:25.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":2695,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award vested on March 10, 2017. This award was originally part of a grant from Emergent BioSolutions Inc. (\"Emergent\") dated March 11, 2014, of which two-thirds were vested at the time of conversion to the issuer's equity pool."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":34.58,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":2695},"source":{"system":"sec-edgar","filing":"0001019056-20-000454","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000454/lamothe.xml","form_type":"4"}},{"id":3200774,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-19T22:34:13.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":134800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on February 17, 2021."}],"balance_after":134800,"derivative":{"exercise_price":0.498,"expiration_date":"2030-02-17","underlying":"Common Stock","underlying_shares":134800},"source":{"system":"sec-edgar","filing":"0001019056-20-000241","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000241/lamothe.xml","form_type":"4"}},{"id":3380330,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-06T01:53:10.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":135384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on November 1, 2020, the one-year anniversary of the grant date."}],"balance_after":135384,"derivative":{"exercise_price":0.576,"expiration_date":"2029-10-31","underlying":"Common Stock","underlying_shares":135384},"source":{"system":"sec-edgar","filing":"0001019056-19-000614","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000614/lamothe.xml","form_type":"4"}},{"id":3619210,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Restricted Stock Unit","published_at":"2019-03-05T02:05:32.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":7318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. 7,320 shares of common stock underlying the RSUs vested on each of March 1, 2017 and March 1, 2018, and the remaining 7,318 shares vested on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. 7,320 shares of common stock underlying the RSUs vested on each of March 1, 2017 and March 1, 2018, and the remaining 7,318 shares vested on March 1, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7318},"source":{"system":"sec-edgar","filing":"0001019056-19-000178","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000178/lamothe.xml","form_type":"4"}},{"id":3619209,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-05T02:05:32.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three approximately equal annual installments beginning on February 28, 2020."}],"balance_after":67400,"derivative":{"exercise_price":1.52,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-19-000178","document":"lamothe.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000178/lamothe.xml","form_type":"4"}},{"id":3619208,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-03-05T02:05:32.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":2170,"price":1.57,"value":3406.9,"ownership":{"direct":true},"balance_after":75024,"source":{"system":"sec-edgar","filing":"0001019056-19-000178","document":"lamothe.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000178/lamothe.xml","form_type":"4"}},{"id":3619207,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Common Stock","published_at":"2019-03-05T02:05:32.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":7318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."}],"balance_after":77194,"source":{"system":"sec-edgar","filing":"0001019056-19-000178","document":"lamothe.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905619000178/lamothe.xml","form_type":"4"}},{"id":3998471,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-14T01:37:25.000Z","date":"2018-03-10","kind":"exercise","acquired":false,"shares":6747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 10, 2018."}],"balance_after":7318,"derivative":{"underlying":"Common Stock","underlying_shares":6747},"source":{"system":"sec-edgar","filing":"0001019056-18-000435","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000435/lamothe_4.xml","form_type":"4"}},{"id":3998470,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2018-03-14T01:37:25.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":67400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":67400,"derivative":{"exercise_price":3.13,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":67400},"source":{"system":"sec-edgar","filing":"0001019056-18-000435","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000435/lamothe_4.xml","form_type":"4"}},{"id":3998469,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-03-14T01:37:25.000Z","date":"2018-03-10","kind":"tax_withholding","acquired":false,"shares":1583,"price":3.13,"value":4954.79,"ownership":{"direct":true},"balance_after":69876,"source":{"system":"sec-edgar","filing":"0001019056-18-000435","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000435/lamothe_4.xml","form_type":"4"}},{"id":3998468,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-03-14T01:37:25.000Z","date":"2018-03-10","kind":"exercise","acquired":true,"shares":6747,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":71459,"source":{"system":"sec-edgar","filing":"0001019056-18-000435","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000435/lamothe_4.xml","form_type":"4"}},{"id":4015589,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2018-03-06T00:38:35.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":7320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019."}],"balance_after":14065,"derivative":{"underlying":"Common Stock","underlying_shares":7320},"source":{"system":"sec-edgar","filing":"0001019056-18-000418","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000418/lamothe_4.xml","form_type":"4"}},{"id":4015588,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-03-06T00:38:35.000Z","date":"2018-03-01","kind":"tax_withholding","acquired":false,"shares":1717,"price":3.04,"value":5219.68,"ownership":{"direct":true},"balance_after":64712,"source":{"system":"sec-edgar","filing":"0001019056-18-000418","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000418/lamothe_4.xml","form_type":"4"}},{"id":4015587,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-03-06T00:38:35.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":7320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":66429,"source":{"system":"sec-edgar","filing":"0001019056-18-000418","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000418/lamothe_4.xml","form_type":"4"}},{"id":4073822,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-07T00:21:32.000Z","date":"2018-02-03","kind":"exercise","acquired":false,"shares":25340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":21385,"derivative":{"underlying":"Common Stock","underlying_shares":25340},"source":{"system":"sec-edgar","filing":"0001019056-18-000287","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000287/lamothe_4.xml","form_type":"4"}},{"id":4073821,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-02-07T00:21:32.000Z","date":"2018-02-03","kind":"tax_withholding","acquired":false,"shares":7514,"price":3.24,"value":24345.36,"ownership":{"direct":true},"balance_after":59109,"source":{"system":"sec-edgar","filing":"0001019056-18-000287","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000287/lamothe_4.xml","form_type":"4"}},{"id":4073820,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2018-02-07T00:21:32.000Z","date":"2018-02-03","kind":"exercise","acquired":true,"shares":25340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":66623,"source":{"system":"sec-edgar","filing":"0001019056-18-000287","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000287/lamothe_4.xml","form_type":"4"}},{"id":4298215,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-02T01:39:49.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the \"Plan\") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":33700,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000547","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000547/lamothe_4.xml","form_type":"4"}},{"id":4388816,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-10","kind":"exercise","acquired":false,"shares":18863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were originally issued by Emergent on March 11, 2014 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs fully vested on March 10, 2017."}],"balance_after":46725,"derivative":{"underlying":"Common Stock","underlying_shares":18863},"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388815,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-10","kind":"exercise","acquired":false,"shares":6746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 6,746 on March 10, 2017 and 6,747 on March 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were originally issued by Emergent on March 10, 2015 and, as a result of the Spin-off, were adjusted and assumed by the Issuer. The RSUs vest as follows: 6,746 on March 10, 2017 and 6,747 on March 10, 2018."}],"balance_after":65588,"derivative":{"underlying":"Common Stock","underlying_shares":6746},"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388814,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-01","kind":"exercise","acquired":false,"shares":7320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the \"Spin-off\"), each RSU was adjusted and assumed by the Issuer. The RSUs vest as follows: 7,320 on March 1, 2017, 7,320 on March 1, 2018 and 7,318 on March 1, 2019."}],"balance_after":72334,"derivative":{"underlying":"Common Stock","underlying_shares":7320},"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388813,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":4990,"price":1.78,"value":8882.2,"ownership":{"direct":true},"balance_after":41284,"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388812,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":18863,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":46274,"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388811,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":1785,"price":1.78,"value":3177.3,"ownership":{"direct":true},"balance_after":27411,"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388810,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":6746,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":29196,"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388809,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-01","kind":"tax_withholding","acquired":false,"shares":1936,"price":2.02,"value":3910.72,"ownership":{"direct":true},"balance_after":22450,"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4388808,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-03-14T01:05:48.000Z","date":"2017-03-01","kind":"exercise","acquired":true,"shares":7320,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":24386,"source":{"system":"sec-edgar","filing":"0001019056-17-000288","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000288/lamothe_4.xml","form_type":"4"}},{"id":4421749,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-27T21:03:58.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in three equal annual installments beginning on February 24, 2018."}],"balance_after":142232,"derivative":{"exercise_price":1.96,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001019056-17-000234","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000234/lamothe_4.xml","form_type":"4"}},{"id":4461611,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-02-08T23:28:24.000Z","date":"2017-02-03","kind":"exercise","acquired":false,"shares":25340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 3, 2016, the reporting person was granted 50,680 RSUs, vesting in two equal installments on February 3, 2017 and February 3, 2018."}],"balance_after":79654,"derivative":{"underlying":"Common Stock","underlying_shares":25340},"source":{"system":"sec-edgar","filing":"0001019056-17-000111","document":"lamothe_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000111/lamothe_4.xml","form_type":"4"}},{"id":4461610,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-02-08T23:28:24.000Z","date":"2017-02-03","kind":"tax_withholding","acquired":false,"shares":8274,"price":1.92,"value":15886.08,"ownership":{"direct":true},"balance_after":17066,"source":{"system":"sec-edgar","filing":"0001019056-17-000111","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000111/lamothe_4.xml","form_type":"4"}},{"id":4461609,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2017-02-08T23:28:24.000Z","date":"2017-02-03","kind":"exercise","acquired":true,"shares":25340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU converts into the Issuer's common stock on a one-for-one basis."}],"balance_after":25340,"source":{"system":"sec-edgar","filing":"0001019056-17-000111","document":"lamothe_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000111/lamothe_4.xml","form_type":"4"}},{"id":4594168,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25018,"kind":"person","name":"Lamothe Jeffrey G.","position":1,"cik":"0001679967","reported_name":"Lamothe Jeffrey G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO and Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2016-09-27T19:42:42.000Z","date":"2016-08-03","kind":"grant","acquired":true,"shares":50680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents the right of the reporting person to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This report has been amended to reflect that the RSUs will vest in two equal installments on February 3, 2017 and February 3, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the 35,451 RSUs that were originally issued by Emergent BioSolutions, Inc. (\"Emergent\") and, as a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, were adjusted and assumed by the Issuer under its Converted Equity Awards Incentive Plan."}],"balance_after":104994,"derivative":{"underlying":"Common Stock","underlying_shares":50680},"source":{"system":"sec-edgar","filing":"0001019056-16-001557","document":"lamothe_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905616001557/lamothe_4a.xml","form_type":"4/A","original_submission_date":"2016-08-05"}}]}